Aethlon Medical AEMD 深 沪
等待开盘 10-09 09:30:00 美东时间
6.01
-0.060
-0.99%
华盛通- 最 高6.09
- 今 开6.02
- 成交量 2.49万股
- 最 低 6.00
- 昨 收 6.07
- 总市值 964.06万
- 52周最高 29.45
- 市盈率 静 --
- 换手率 1.55%
- 52周最低 1.41
- 委 比 17.12%
- 总股本 160.41万
- 历史最高 2160000.00
- 量 比 0.41
- 振 幅 1.48%
- 历史最低 2.625
- 每 手 1
- 风险率 7.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aethlon Medical Shareholders Expand Capital Structure Flexibility
Aethlon Medical ( ($AEMD) ) has shared an announcement. On October 1, 2026, Aet...
10-02 05:49
Are PRTH, MG, AEMD Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
09-22 02:30
Aethlon Medical Q1 2027 Earnings Call Transcript
Aethlon Medical (NASDAQ:AEMD) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. View the webcast at https://dpr...
09-18 17:28
Aethlon Medical Pivots to Biotechnology with All-Stock Merger
Aethlon Medical Inc. (NASDAQ:AEMD) stock on Thursday skyrocketed after the company signed an all-stock merger agreement with privately held biotech firm North Immunology Inc. The merger will create a combined company that will trade on the Nasdaq Capital Market under the ticker symbol NRTX. Backed b...
09-17 20:29
Aethlon Medical To Merge With North Immunology; AEMD Holders To Retain ~4.75% Of Combined Company, With North Immunology Stockholders To Own ~95.25%; NewCo Expected To Have Pro Forma Equity Value Of ~$346.5M; Oversubscribed $180M Private Placement Expected To Fund NewCo Operations Into H2 2028
Aethlon Medical, Inc. (NASDAQ:AEMD) ("Aethlon" or the "Company") today announced that it has entered into a definitive merger agreement (the "Agreement") for an all-stock transaction with North Immunology, Inc. ("North Immunology"), Nighthawk Merger Sub Corp., a wholly owned subsidiary of Aethlon, a...
09-17 18:35
Aethlon Medical Completes Warrant Exercises, Clarifying Capitalization
An announcement from Aethlon Medical ( ($AEMD) ) is now available. Aethlon Medi...
08-31 21:51
Pre-Bell Movers | WHLR Rises by 125.9%; Here Are 20 Stocks Moving Premarket (Aug 28)
US stock futures mixed as markets await Fed Chair Warsh’s Jackson Hole speech, with big moves in premarket trading driven by earnings, guidance, and M&A news.
08-28 16:29
Aethlon Medical Q1 EPS $(4.02) Misses $(0.79) Estimate; Cash & Equivalents $4.9M
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(4.02) per share which missed the analyst consensus estimate of $(0.79) by 415.38 percent. This is a 90.52 percent increase over losses of $(42.42) per share from the same period last year.
08-14 04:17
Aethlon Medical Announces Reverse Stock Split Implementation
Aethlon Medical ( ($AEMD) ) has provided an announcement. On July 30, 2026, Aet...
07-31 20:29
Aethlon Medical Prices $4M Follow-On Offering Of 5,633,009 Shares And Warrants At $0.7101 Per Unit
Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of its follow-on offering of 5,633,009 shares of its common stock (or pre-funded warrants in lieu thereof) and warra...
07-06 21:27
